欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0139/004
药品名称
Detrusitol SR
活性成分
Tolterodine tartrate 4.0 mg
剂型
Prolonged-release capsule*
上市许可持有人
Upjohn EESV, Netherlands
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Belgium (BE)
Netherlands (NL)
Luxembourg (LU)
Iceland (IS)
United Kingdom (Northern Ireland) (XI)
Ireland (IE)
Austria (AT)
Detrusitol retard 4 mg - Kapseln
Spain (ES)
Italy (IT)
Greece (GR)
Norway (NO)
Finland (FI)
许可日期
2001/07/11
最近更新日期
2025/01/16
药物ATC编码
G04BD07 tolterodine
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier Article 4.8 Di 65/65
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0139_004_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0139_004_Final SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase